We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Bladder Cancer

Journal Scan / Research · May 03, 2021

Survival and Oncologic Outcomes of Complete TURBT Prior to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer

Urologic Oncology: Seminars & Original Investigations

 

Additional Info

Urologic Oncology: Seminars & Original Investigations
Survival and Oncologic Outcomes of Complete Transurethral Resection of Bladder Tumor Prior to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Urol. Oncol 2021 Apr 14;[EPub Ahead of Print], JS Pak, CR Haas, CB Anderson, GJ DeCastro, MC Benson, JM McKiernan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading